Literature DB >> 8648784

Vaginal wall sling for anatomical incontinence and intrinsic sphincter dysfunction: efficacy and outcome analysis.

S Raz1, L Stothers, G P Young, J Short, B Marks, A Chopra, G R Wahle.   

Abstract

PURPOSE: A prospective cohort study was done to determine the efficacy and clinical outcome of a new technique for anterior vaginal wall sling construction to treat urinary incontinence due to intrinsic sphincter dysfunction or anatomical incontinence.
MATERIALS AND METHODS: Preoperative evaluation included lateral cystography, video urodynamics, cystoscopy and incontinence staging. Postoperative subjective and objective staging outcome measures were prospectively assigned at predetermined regular intervals by a third party.
RESULTS: Of the patients 95 had intrinsic sphincter dysfunction and 65 had anatomical incontinence. The repair failed in 7% of the 160 patients who had recurrent incontinence during followup and 9% had de novo urgency incontinence. Time to failure comparing patients with intrinsic sphincter dysfunction and anatomical incontinence was modeled using Kaplan-Meier survival curves, and the log rank test showed no significant difference between the groups (p > 0.05). Logistic regression covariates revealed no significant predictive factors for postoperative failures. Preoperative patient age was the only predictive factor for de novo instability (logistic regression model p < 0.05).
CONCLUSIONS: Our initial results indicate that the 2 groups are indistinguishable to date based on current clinical and experimental statistics except for time to full recovery of postoperative voiding and incidence of postoperative instability (regression model p < 0.05).

Entities:  

Mesh:

Year:  1996        PMID: 8648784

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  12 in total

1.  Modified insitu vaginal wall sling in stress incontinence.

Authors:  A Metin; O Kayigil; S I Ahmed
Journal:  Int Urol Nephrol       Date:  2001       Impact factor: 2.370

2.  In situ anterior vaginal wall sling formation with preservation of the endopelvic fascia for treatment of stress urinary incontinence.

Authors:  S P Vasavada; R R Rackley; R A Appell
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  1998

Review 3.  Pubovaginal slings: past, present and future.

Authors:  R Sarver; F E Govier
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  1997

4.  The UCLA surgical approach to sphincteric incontinence in women.

Authors:  E S Rovner; D A Ginsberg; S Raz
Journal:  World J Urol       Date:  1997       Impact factor: 4.226

Review 5.  Surgical treatment of sphincteric incontinence in women.

Authors:  S L Stanton
Journal:  World J Urol       Date:  1997       Impact factor: 4.226

6.  Assessing outcome after a modified vaginal wall sling for stress incontinence with intrinsic sphincter deficiency.

Authors:  Elisabetta Costantini; Luigi Mearini; Ettore Mearini; Cinzia Pajoncini; Federico Guercini; Vittorio Bini; Massimo Porena
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2004-10-22

7.  Voiding function after a modified no-tension pubovaginal sling.

Authors:  Hilary J Cholhan; Peter M Lotze
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2004 Jul-Aug

8.  The distribution of different surgical types for female stress urinary incontinence among patients' age, surgeons' specialties and hospital accreditations in Taiwan: a descriptive 10-year nationwide study.

Authors:  Ming-Ping Wu; Kuan-Hui Huang; Cheng-Yu Long; Kuo-Feng Huang; Ken-Jen Yu; Chao-Hsiun Tang
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2008-08-12

9.  Predictors of outcome after in situ anterior vaginal wall sling surgery.

Authors:  H Kilicarslan; G Gokce; S Ayan; T Guvenal; K Kaya; E Y Gultekin
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2003-09-19

10.  Is the efficacy of in situ vaginal wall slings decreasing in the late follow-up?

Authors:  Ahmet Metin; Onder Kayigil; S Iftekhar Ahmed; Ali Fuat Atmaca
Journal:  Int Urol Nephrol       Date:  2007-06-30       Impact factor: 2.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.